An article by Mr. Mohammad Yasir Essar, a researcher at Kateb Medical Research Center, entitled “The Impact of COVID-19 on Patients With Schizophrenia and Their Access to Health Care” was published in international prestigious journal of “The Primary Care Companion for CNS Disorders” with the affiliation of Kateb University.
Abstract:
Schizophrenia is a medical condition characterized by symptoms of psychosis that can be persistent or relapsing. The major signs include hallucinations (typically hearing voices), delusions, and disorganized thinking, while social detachment, diminished emotional expression, and apathy are also not uncommon.
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus, has infected more than 100 million individuals worldwide and caused many deaths, making it a significant concern for all health care systems. Although the global prevalence of schizophrenia is 0.4%, it is a major burden on families and has several cultural implications. Patients with schizophrenia have a higher mortality rate with significant comorbid conditions. The increasing spread of COVID-19 has thus raised serious concerns that the clinical effects of the disease, particularly in regard to the increasing prevalence of schizophrenia, may become evident in subsequent years, in addition to the acute psychiatric problems associated with the current diagnosis.
Interested people can find the article here.
Comment is not allowed
